Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema

Abstract

Micropulse laser is a safe and effective treatment for DME, which may achieve comparable improvement in VA along with a significant reduction in the burden of anti-VEGF injections. We suggest a treatment approach for its inclusion in the early stages of DME.